Nuclear factor-kappa beta (NF-kB) and Rel (RelA, RelB, and c-Rel) play crucial roles in the pathogenesis, cancer progression, and apoptosis resistance of PDAC and might be potential therapeutic targets [30,31]. Here, REL is linked to cancer.